MACQUARIE GROUP LTD - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$24,000
+20.0%
0
-100.0%
0.00%
Q2 2022$20,000
-31.0%
5100.0%0.00%
Q1 2022$29,000
-29.3%
5100.0%0.00%
Q4 2021$41,000
+86.4%
510
+105.6%
0.00%
Q3 2021$22,000
-31.2%
2480.0%0.00%
Q2 2021$32,000
+60.0%
2480.0%0.00%
Q1 2021$20,000
-33.3%
248
-32.1%
0.00%
Q4 2020$30,000
+233.3%
3650.0%0.00%
Q3 2020$9,000
-10.0%
3650.0%0.00%
Q2 2020$10,0003650.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders